"Synergistic targeting of KRAS-mutant cancers through combined inhibition of LDHA and FDAapproved anticancer agents


Güler S., Onguncan O., Yalçın A.

16. Ulusal-2.Uluslararası Histoloji ve Embriyoloji Kongresi, Sakarya, Turkey, 26 - 28 September 2024, pp.1, (Summary Text)

  • Publication Type: Conference Paper / Summary Text
  • City: Sakarya
  • Country: Turkey
  • Page Numbers: pp.1
  • Bursa Uludag University Affiliated: Yes